Corvus Pharmaceuticals Inc sell StockNews.com
Start price
03.04.23
/
50%
€0.92
Target price
03.04.24
-
Performance (%)
81.96%
End price
04.04.24
€1.67
Summary
This prediction ended on 04.04.24 with a price of €1.67. The price for Corvus Pharmaceuticals Inc massively increased, which is bad news for the SELL prediction by StockNews_com. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Corvus Pharmaceuticals Inc | -5.200% | -5.200% | -6.447% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by StockNews_com for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CRVS provided by MarketBeat
In the thread Trading Corvus Pharmaceuticals Inc
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€4.55
28.09.24
28.09.24
-
28.09.25
28.09.25
32.97%
29.09.25
29.09.25
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€0.65
26.03.23
26.03.23
-
26.03.24
26.03.24
144.58%
27.03.24
27.03.24
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€0.68
18.03.23
18.03.23
-
18.03.24
18.03.24
157.58%
19.03.24
19.03.24